» Articles » PMID: 18347934

Matrix Metalloproteinase-9 Expression in the Normal Mucosa-adenoma-dysplasia-adenocarcinoma Sequence of the Colon

Overview
Specialty Oncology
Date 2008 Mar 19
PMID 18347934
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

It has been proposed that matrix metalloproteinases (MMPs) play a role in tumor invasion. We determined protein expression of matrix metalloproteinase-9 (MMP-9) in colorectal cancer (CRC), corresponding normal mucosa and colorectal adenomas. For confirmation of immunohistochemical results MMP-9 TaqMan RT-PCR analysis was performed. Expression of MMP-9 was determined on paraffin embedded biopsy sections by immunohistochemistry in 31 CRC patients (from cancer tissue and corresponding normal mucosa) and in 30 patients with adenoma (nine adenomas with high grade of dysplasia). MMP-9 immunostaining was determined semi-quantitatively. For Taqman RT-PCR analyses normal mucosa (n = 5), adenoma without (n = 6) and with high grade dysplasia (n = 7) and CRC (n = 10) were investigated. Statistical analysis with ANOVA, LSD test and correlation analysis were performed. P value of <0.05 was considered significant. The MMP-9 expression in CRC was significantly higher compared to adenomas or the normal mucosa (P = 0.001). Significantly higher expression of MMP-9 has been observed in adenomas with high grade dysplasia compared to other adenomas or normal colon (P < 0.001). Diffuse strong MMP-9 expression was present in tumor as well as in stromal cells. In adenoma samples, dysplastic epithelial cells showed moderate intensive cytoplasmic MMP-9 expression, with a clear-cut differentiation between dysplastic and non-dysplastic areas. Staining intensity correlated with the grade of CRC. We demonstrate a significantly higher expression of MMP-9 in adenoma with high grade dysplasia-CRC sequence as compared to normal tissue. The over-expression of MMP-9 strongly suggests its association with colorectal carcinogenesis.

Citing Articles

Modulation of host N6-methyladenosine modification by gut microbiota in colorectal cancer.

Jiang T, Wang H, Cheng W, Xie C World J Gastroenterol. 2024; 30(38):4175-4193.

PMID: 39493326 PMC: 11525875. DOI: 10.3748/wjg.v30.i38.4175.


Correlating Ultrastructural Changes in the Invasion Area of Colorectal Cancer with CT and MRI Imaging.

Urbaniec-Stompor J, Michalak M, Godlewski J Int J Mol Sci. 2024; 25(18).

PMID: 39337393 PMC: 11432200. DOI: 10.3390/ijms25189905.


Plasma Circulating mRNA Profile for the Non-Invasive Diagnosis of Colorectal Cancer Using NanoString Technologies.

Tsang H, Pei X, Wong Y, Wong S Int J Mol Sci. 2024; 25(5).

PMID: 38474258 PMC: 10932272. DOI: 10.3390/ijms25053012.


Identification of Differentially Expressed Genes and miRNAs for Ulcerative Colitis Using Bioinformatics Analysis.

Hu W, Fang T, Chen X Front Genet. 2022; 13:914384.

PMID: 35719390 PMC: 9201719. DOI: 10.3389/fgene.2022.914384.


Circulating Biomarkers of Colorectal Cancer (CRC)-Their Utility in Diagnosis and Prognosis.

Lukaszewicz-Zajac M, Mroczko B J Clin Med. 2021; 10(11).

PMID: 34071492 PMC: 8199026. DOI: 10.3390/jcm10112391.


References
1.
Illemann M, Bird N, Majeed A, Sehested M, Laerum O, Lund L . MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res. 2006; 4(5):293-302. DOI: 10.1158/1541-7786.MCR-06-0003. View

2.
Curran S, Dundas S, Buxton J, Leeman M, Ramsay R, Murray G . Matrix metalloproteinase/tissue inhibitors of matrix metalloproteinase phenotype identifies poor prognosis colorectal cancers. Clin Cancer Res. 2004; 10(24):8229-34. DOI: 10.1158/1078-0432.CCR-04-0424. View

3.
Plebani M, Herszenyi L, Cardin R, Roveroni G, Carraro P, Paoli M . Cysteine and serine proteases in gastric cancer. Cancer. 1995; 76(3):367-75. DOI: 10.1002/1097-0142(19950801)76:3<367::aid-cncr2820760304>3.0.co;2-b. View

4.
Johnson L, Dyer R, Hupe D . Matrix metalloproteinases. Curr Opin Chem Biol. 1998; 2(4):466-71. DOI: 10.1016/s1367-5931(98)80122-1. View

5.
Lubbe W, Zhou Z, Fu W, Zuzga D, Schulz S, Fridman R . Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res. 2006; 12(6):1876-82. DOI: 10.1158/1078-0432.CCR-05-2686. View